Association of ATP-binding cassette transporter variants with the risk of Alzheimer's disease by Cascorbi Ingolf, Flüh Charlotte, Remmler Cornelia, Haenisch Sierk, Faltraco Frank, Grumbt Maria, Peters Michele, Brenn Anja, Thal Dietmar Rudolf, Warzok Rolf Wolfgang, Vogelgesang Silke in Pharmacogenomics (2013).

[PMID: 23556446] PubMed


Aim: A number of studies have demonstrated that ABCB1 and BCRP (ABCG2) actively transport Abeta. We aimed to investigate the association of genetic variants of selected multidrug transporters with Alzheimer's disease (AD) in histopathologically confirmed AD cases and controls. Materials & methods: DNA from brain tissue of 71 AD cases with Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropathological stages B/C and 81 controls was genotyped for selected variants in ABCA1, ABCA7, ABCB1, ABCC2 and ABCG2. In addition, the APOE4 status was analyzed. Results: The novel ABCA7 SNP, rs3752246, tended to be associated with AD in our study. Variants in ABCB1 were significantly less frequent in AD cases older than 65 years of age and among females. This association of ABCB1 2677G>T (rs2032582) was more pronounced in APOE4-negative cases (p = 0.005). However, only ABCC2 3972C>T (rs3740066) was significantly associated with AD risk after logistic regression analysis including all variants. Other transporters showed a lack of association. Conclusion: Our results support the hypothesis that ABCB1 and possibly other ABC-transporters are involved in the process of Abeta accumulation in the aging brain and may modulate the risk for AD in an allele-specific manner, and thus might represent a new target for prevention and treatment of AD. Original submitted 8 October 2012; Revision submitted 22 January 2013.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.